
Goodnoct 6.25mg Tablet XR
Marketer
Lupin Ltd
Salt Composition
Zolpidem (6.25mg)
Overview Goodnoct 6.25mg Tablet XR
Somnus 6.25mg Extended-Release Tablets are indicated for the short-term management of sleeplessness. They shorten the time it takes to fall asleep and lessen nighttime awakenings, promoting sustained sleep. Somnus 6.25mg Extended-Release Tablets should be ingested on an empty stomach, ideally just before bedtime. Consistent daily timing helps maintain therapeutic blood levels. Follow your physician's prescribed dosage and duration, as this medication can be habit-forming; do not discontinue use abruptly without consulting your doctor, as this could exacerbate symptoms. Potential side effects include impaired memory, visual disturbances, restlessness, headache, dizziness, gastrointestinal upset (diarrhea, nausea, vomiting), back pain, fatigue, and depression. While generally transient, persistent or bothersome effects necessitate medical attention. Somnus 6.25mg Extended-Release Tablets can induce drowsiness and dizziness; avoid driving or tasks requiring alertness until the medication's effects are known. Alcohol consumption should be avoided. Report any unusual mood shifts, new or worsening depression, hallucinations, or suicidal ideation to your doctor immediately. Before commencing treatment, disclose all other medications to your physician to ensure appropriate usage. Pre-existing liver or kidney conditions warrant medical consultation prior to starting Somnus 6.25mg Extended-Release Tablets. Smoking and alcohol should be avoided during treatment. This medication is contraindicated during pregnancy and breastfeeding; consult your physician if necessary.
Primary Ingredients of Goodnoct 6.25mg Tablet XR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Goodnoct 6.25mg Tablet XR
Managing Sleep Difficulties
Major Benefits of Goodnoct 6.25mg Tablet XR:
Consume this medication precisely as prescribed by your physician, adhering to the advised dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or breaking it. Administer Goodnoct 6.25mg Extended-Release Tablet on an empty stomach.
Common Side effects of Goodnoct 6.25mg Tablet XR:
- Dizziness
- Sleepiness
- Headache
- Nausea
- Stomach pain
- Memory loss
- Vertigo
- Vomiting
- Back pain
- Agitation
- Double vision
- Depression
How to use Goodnoct 6.25mg Tablet XR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet; avoid chewing, crushing, or breaking it. Administer Goodnoct 6.25mg Extended-Release Tablet on an empty stomach.
How Goodnoct 6.25mg Tablet XR works:
SomniRest 6.25mg Extended-Release Tablets are classified as non-benzodiazepine sleep aids. This medication exhibits hypnotic, sedative, and anticonvulsive effects, controlling seizures. Its mechanism involves interaction with the GABAA receptor chloride channel complex, a neurotransmitter receptor, to reduce neuronal activity in the brain, thus promoting sleep onset.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Goodnoct 6.25mg extended-release tablets and alcohol can lead to significant somnolence.
PregnancyCONSULT YOUR DOCTOR
Extended-release Goodnoct 6.25mg tablets might pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Goodnoct 6.25mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to infants.
DrivingUNSAFE
Extended-release Goodnoct 6.25mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Individuals with kidney disease can safely use Goodnoct 6.25mg extended-release tablets without a dosage modification. Nevertheless, disclosure of any kidney condition to your physician is advised.
LiverCAUTION
Patients with liver impairment should use Goodnoct 6.25mg XR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should begin with a low Goodnoct 6.25mg XR tablet dosage; however, it's unsuitable for patients exhibiting severe hepatic dysfunction.
What if you forget to take Goodnoct 6.25mg Tablet XR :
Omit any missed Goodnoct 6.25mg Extended-Release Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Goodnoct 6.25mg Tablet XR
| Label | Value |
|---|---|
| Chemical Type | Imidazopyridine compound |
| Developing Habits | Affirmative. |
| Treatment Category | Central Nervous System (CNS) Neurobiology |
| Behavior Class | Non-benzodiazepine sleeping medications (Z-drugs) |
